400 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Elkhorn Partners Limited Partnership

Elkhorn Partners Limited Partnership purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 400 shares of the company’s stock, valued at approximately $31,000.

Several other hedge funds have also bought and sold shares of GEHC. Vanguard Group Inc. grew its holdings in GE HealthCare Technologies by 9.2% during the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after purchasing an additional 4,107,746 shares during the period. Norges Bank bought a new stake in GE HealthCare Technologies during the fourth quarter valued at about $229,052,000. Capital Research Global Investors grew its holdings in GE HealthCare Technologies by 5.2% during the first quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after purchasing an additional 2,647,204 shares during the period. Perpetual Ltd bought a new stake in GE HealthCare Technologies during the first quarter valued at about $96,135,000. Finally, Jacobs Levy Equity Management Inc. grew its holdings in GE HealthCare Technologies by 4,959.8% during the first quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock valued at $68,957,000 after purchasing an additional 743,523 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.2 %

GEHC opened at $86.79 on Wednesday. The stock has a market cap of $39.62 billion, a price-to-earnings ratio of 25.38, a P/E/G ratio of 3.26 and a beta of 1.17. The stock’s 50 day moving average price is $83.26 and its 200-day moving average price is $83.31. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. During the same quarter in the prior year, the firm earned $0.92 earnings per share. GE HealthCare Technologies’s revenue was up .5% compared to the same quarter last year. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a dividend of $0.03 per share. The ex-dividend date was Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price on the stock. Finally, Stifel Nicolaus assumed coverage on GE HealthCare Technologies in a research report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 target price on the stock. Six investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $94.58.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.